Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TADALAFIL vs TAFAMIDIS MEGLUMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TADALAFIL vs TAFAMIDIS MEGLUMINE: Safety Overview

Metric TADALAFIL TAFAMIDIS MEGLUMINE
Total FAERS Reports 30,683 4,405
Deaths Reported 3,553 1,718
Death Rate 11.6% 39.0%
Hospitalizations 8,717 1,334
Average Patient Age 58.7 yrs 78.7 yrs
% Female Patients 42.7% 17.0%
FDA Approval Date Apr 29, 2019 May 3, 2019
Manufacturer Guangzhou Yixin Cross-border E-commer... Pfizer Laboratories Div Pfizer Inc
Route TOPICAL ORAL
Marketing Status Prescription Discontinued